Massar Capital Management, LP
Source: SEC Form 13F · as of Mar 2026Massar Capital Management, LP holds 13 biotech & pharma companies tracked by BioSniper, totaling $18.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$18.8M
| Company | Shares | Value |
|---|---|---|
| QUREuniQure N.V. | 426,029 | $7.0M |
| MOHMolina Healthcare Inc | 47,271 | $6.3M |
| CLPTClearPoint Neuro Inc. | 206,970 | $1.9M |
| ACHAccendra Health Inc. | 421,120 | $960K |
| INDVIndivior Pharmaceuticals, Inc. | 13,613 | $415K |
| CPRXCATALYST PHARMACEUTICALS, INC. | 15,382 | $381K |
| GMEDGlobus Medical Inc. | 4,411 | $380K |
| TGTXTG THERAPEUTICS, INC. | 10,029 | $333K |
| STIMNeuronetics Inc. | 221,000 | $320K |
| NVONovo Nordisk A/S | 8,422 | $310K |
| TWSTTwist Bioscience Corp | 5,500 | $261K |
| PBIPROVENTION BIO, INC. | 14,966 | $165K |
| ADMAADMA BIOLOGICS, INC. | 15,170 | $137K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.